| View |
|
DRP-9955-01
|
Citicoline (as sodium)
|
Citinerve
|
500 mg
|
Capsule
|
Psychostimulant and Nootropic
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
17 March 2022
|
23 March 2026
|
| View |
|
DRP-11087-01
|
Co-Amoxiclav
|
Clavco
|
457 mg/ 5 mL P
|
owder for Oral Suspension (Raspberry Flavor)
|
Antibacterial (Penicillin/Beta Lactamase Inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
-
|
17 March 2022
|
03 February 2027
|
| View |
|
DRP-4013-05
|
Carbamazepine
|
None
|
200 mg
|
Tablet
|
Antiepileptic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
16 March 2022
|
09 October 2025
|
| View |
|
DRP-8636-02
|
Erythromycin (as stearate)
|
Ameryth
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Theon Pharmaceuticals Limited
|
India
|
-
|
16 March 2022
|
17 January 2025
|
| View |
|
DRP-9695-01
|
Levofloxacin (as hemihydrate)
|
Voxelacin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
16 March 2022
|
05 May 2026
|
| View |
|
DRP-11497
|
Paclitaxel
|
Unbranded
|
6 mg/mL
|
Concentrate Solution for I.V. Infusion
|
Antineoplastics (Cell Cycle-Specific Agents)
|
Ebewe Pharma Ges M.B.H. NFG KG
|
Australia
|
Renewal
|
05 January 2023
|
05 April 2028
|
| View |
|
DRP-11486
|
Diosmin + Hesperidin
|
Hespadin
|
450 mg/50 mg
|
Film-Coated Tablet
|
-
|
Pell Tech Health Care Pvt. Ltd
|
India
|
-
|
16 March 2022
|
08 June 2025
|
| View |
|
DRP-5025-44
|
Omeprazole (as sodium)
|
Inoby
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump (H+K+ATPase) Inhibitor
|
Shreechem Pharmaceuticals Pvt. Ltd
|
India
|
Renewal
|
12 June 2023
|
27 December 2028
|
| View |
|
DRP-11295-02
|
Ambroxol Hydrochloride
|
None
|
30 mg
|
Tablet
|
Mucolytic
|
Centurion Laboratories Pvt. Ltd
|
India
|
-
|
15 March 2022
|
24 November 2026
|
| View |
|
DRP-4854-12
|
Esomeprazole (as sodium)
|
Cleazole
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Brawn Laboratories Limited
|
India
|
Renewal
|
14 January 2023
|
23 October 2028
|
| View |
DRP-6741-03_PI_01.pdf
|
DRP-6741-03
|
Montelukast
|
Leukast
|
10 mg
|
Film-Coated Tablet
|
LEUKOTRIENE RECEPTOR ANTAGONIST
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
11 March 2022
|
15 July 2025
|
| View |
|
DRP-7410-02
|
Folic Acid
|
Holivit
|
5 mg
|
Tablet
|
ANTIANEMIA
|
Hiral Labs Limited
|
India
|
-
|
11 March 2022
|
22 February 2026
|
| View |
|
DRP-10476-02
|
Telmisartan
|
Elzar 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Globela Pharma Private Limited
|
India
|
-
|
11 March 2022
|
30 September 2026
|
| View |
|
DRP-2985-09
|
Azithromycin (as Dihydrate)
|
Dielzith
|
500 mg
|
Tablet
|
Antibacterial
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
05 February 2024
|
16 June 2029
|
| View |
|
DRP-3139-01
|
CETIRIZINE DIHYDROCHLORIDE
|
EFRIZINE
|
10 mg
|
Film-Coated Tablet
|
H1- RECEPTOR ANTAGONIST
|
Syncom Formulations (India) Ltd
|
India
|
|
14 June 2023
|
27 July 2028
|
| View |
|
DRP-11107-01
|
Ascorbic Acid + Zinc
|
Hero-C
|
500mg (equivalent to 562.5 mg Sodium Ascorbate) / 10mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Capsule
|
VITAMIN/MINERAL
|
Pharmatechnica Laboratory, Inc
|
Philippines
|
-
|
10 March 2022
|
02 February 2027
|
| View |
|
DRP-1142
|
Levetiracetam
|
Levacetam
|
100 mg/mL(500mg/5mL)
|
Concentrated Solution for Injection ( IM/IV)
|
-
|
Micro Labs Limited
|
India
|
-
|
10 March 2022
|
11 May 2026
|
| View |
|
BRP-073-02
|
Tetanus Antitoxin
|
tetAMSON
|
1500 IU/0.7 mL
|
Solution for Injection (Equine)
|
-
|
Jiangxi Institute of Biological Products
|
China
|
-
|
09 March 2022
|
04 December 2024
|
| View |
|
DRP-4473-01
|
Epirubicin (as hydrochloride)
|
None
|
50 mg
|
Lyophilized Powder for Intravenous Injection
|
Antineoplastic
|
Khandelwal Laboratories Pvt. Ltd
|
India
|
-
|
09 March 2022
|
13 June 2026
|
| View |
|
DRP-5515-02
|
Piperacillin (as sodium) / Tazobactam (as sodium)
|
Aezar
|
2 g/250 mg
|
Powder for Injection (IV)
|
Antibacterial
|
Zeiss Pharmaceuticals Pvt. Limited
|
India
|
Renewal
|
29 March 2024
|
12 November 2029
|